Avanos Medical, Inc. Announces Second Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- Wall St set for higher open as AI stocks rise, oil slides
Avanos Medical, Inc. (AVNS) Tops Q2 EPS by 3c; Offers FY22 Guidance
August 9, 2022 7:05 AM EDTAvanos Medical, Inc. (NYSE: AVNS) reported Q2 EPS of $0.41, $0.03 better than the analyst estimate of $0.38. Revenue for the quarter came in at $203 million versus the consensus estimate of $208.28 million.
GUIDANCE:
Avanos Medical, Inc. sees FY2022 EPS of $1.45-$1.65, versus the... More
